Immunogenicity of mucosal COVID-19 vaccine candidates based on the highly attenuated vesicular stomatitis virus vector (VSVMT) in golden syrian hamster

COVID-19 is caused by coronavirus SARS-CoV-2. Current systemic vaccines generally provide limited protection against viral replication and shedding within the airway. Recombinant VSV (rVSV) is an effective vector which inducing potent and comprehensive immunities. Currently, there are two clinical t...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Yong Ke, En Zhang, Jianming Guo, Xiaoxiao Zhang, Lei Wang, Duo Chen, Xinkui Fang, Jianwei Zhu, Feng Li, Tao Sun, Baohong Zhang
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Elsevier 2023-12-01
سلاسل:	Acta Pharmaceutica Sinica B
الموضوعات:	COVID-19 Vesicular stomatitis virus Matrix protein mutant Mucosal Vaccine Spike protein Variants of concerns
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2211383523003295
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!